(lp0
S'Traders Secrets on BioCryst Pharmaceuticals, Inc. , SVB Financial Group ... StockNewsJournal - 16 hours ago ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.'
p1
aS"The Reason Behind BioCryst Pharmaceuticals, Inc.'s 12% Pop Higher Motley Fool - Mar 8, 2017 Shares of BioCryst Pharmaceuticals , a biotech company that develops small-molecule drugs to block enzymes involved in disease proliferation, surged as much as 12% today after a report was issued that a highly pathogenic H5N1 bird flu&nbsp;...BioCryst Pharmaceuticals Prices Public Offering of Common Stock - GlobeNewswire "
p2
aS"Here's Why BioCryst Pharmaceuticals Inc. Catapulted Higher by as Much as 17% Motley Fool - Feb 28, 2017 Shares of BioCryst Pharmaceuticals , a biopharmaceutical company primarily focused on the development of small-molecule drugs that block enzymes associated with the development of diseases, catapulted higher by as much as 17%&nbsp;...BioCryst Pharmaceuticals, Inc. : A Discount Entry? - Market ExclusiveBioCryst reverses premarket, down 24% - Seeking Alpha"
p3
aS'Buy, Sell or Hold? Analysts Approach: Instructure, Inc. , BioCryst ... The USA Commerce - 13 hours ago Latest closing price was 5.79% above its 50-day moving average and 10.04% above its 200-day moving average. On 03/27/2017 close, BioCryst Pharmaceuticals, Inc.  rose 1.14% to $8.89. The stock currently has a Market Cap of $681.42M.BioCryst Pharmaceuticals, Inc.  Receives Average Recommendation of Buy ... - Chaffey BreezeBioCryst Pharmaceuticals, Inc.  Reaches $8.66 After 9.00% Down Move ... - Herald KS'
p4
aS'BioCryst Pharmaceuticals, Inc.  Files An 8-K Entry into a ... Market Exclusive - Mar 17, 2017 BioCryst Pharmaceuticals, Inc.  is a biotechnology company. The Company designs, optimizes and develops small molecule drugs that block enzymes involved in the pathogenesis of diseases.BioCryst Pharmaceuticals, Inc.  Makes The Move To Publicize Its ... - Journal TranscriptDenbury Resources Inc. , BioCryst Pharmaceuticals, Inc.  Stock Eyes ... - The USA Commerce'
p5
aS'BioCryst Pharmaceuticals Inc.  Breaks into New 52-Week High on March 20 ... Equities.com - Mar 20, 2017 Shares of BioCryst Pharmaceuticals Inc.  broke into a new 52-week high yesterday, hitting a peak of $9.21. Shares closed at $9.20 after opening at $8.82 for a move of 3.95%.'
p6
aS'BioCryst Pharmaceuticals Inc.  Breaks into New 52-Week High on March 21 ... Equities.com - Mar 21, 2017 Shares of BioCryst Pharmaceuticals Inc.  broke into a new 52-week high yesterday, hitting a peak of $9.25. Shares closed at $8.29 after opening at $9.25 for a move of -9.89%.'
p7
aS'Stock Returns: Advanced Accelerator Applications SA  versus ... CML News - Mar 27, 2017 This is a snapshot to compare the stock returns for Advanced Accelerator Applications S.A.  versus BioCryst Pharmaceuticals Inc  . The stock return points we compare look at the last three-months, six-months and&nbsp;...'
p8
aS'BioCryst Pharmaceuticals Inc.  Plunges 9.89% on March 21 Equities.com - Mar 21, 2017 BioCryst Pharmaceuticals Inc.  had a rough trading day for Tuesday March 21 as shares tumbled 9.89%, or a loss of $-0.91 per share, to close at $8.29.'
p9
aS'Revenue Approximations Analysis: BioCryst Pharmaceuticals, Inc. , xG ... StockNewsJournal - Mar 22, 2017 BioCryst Pharmaceuticals, Inc.  have shown a high EPS growth of 9.90% in the last 5 years and has earnings decline of -26.80% yoy.Insider Trading Activity BioCryst Pharmaceuticals, Inc.   CFO ... - Market ExclusiveWhat Analysts are Predicting For BioCryst Pharmaceuticals, Inc. (BCRX ... - The USA Commerce'
p10
a.